GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DT&CRO Co Ltd (XKRX:383930) » Definitions » Total Stockholders Equity

DT&CRO Co (XKRX:383930) Total Stockholders Equity : ₩27,069 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is DT&CRO Co Total Stockholders Equity?

DT&CRO Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩27,069 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. DT&CRO Co's Book Value per Share for the quarter that ended in Mar. 2024 was ₩2,126.30. The ratio of a company's debt over equity can be used to measure how leveraged this company is. DT&CRO Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.65.


DT&CRO Co Total Stockholders Equity Historical Data

The historical data trend for DT&CRO Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DT&CRO Co Total Stockholders Equity Chart

DT&CRO Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
-4,207.57 18,005.57 46,320.59 31,678.92

DT&CRO Co Quarterly Data
Jun21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 47,643.75 45,502.61 42,773.30 31,678.92 27,068.85

DT&CRO Co  (XKRX:383930) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

DT&CRO Co's Book Value per Share for the quarter that ended in Mar. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

DT&CRO Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DT&CRO Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of DT&CRO Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


DT&CRO Co (XKRX:383930) Business Description

Traded in Other Exchanges
N/A
Address
28, Baengnyeong-ro 20beon-gil, 2nd, 3rd, 4th floor, Na-dong, Cheoin-gu, Gyeonggi-do (Yubang-dong), Yongin-si, KOR, 17042
DT&CRO Co Ltd conducts a series of consigned research, from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics and medical devices, to analysis, bioactivity, clinical trials, and licensing consulting. provided as a service.

DT&CRO Co (XKRX:383930) Headlines

No Headlines